Comparable efficacy and less toxicity of pegylated liposomal doxorubicin versus epirubicin for neoadjuvant chemotherapy of breast cancer: a case-control study

por Dong, Minjun, Luo, Liang, Ying, Xiaogang, Lu, Xianqiu, Shen, Jianguo, Jiang, Zhinong, Wang, Linbo
Publicado 2018